The Globe and Mail reports in its Friday edition that Wealthsimple is offering retail investors shares in select Canadian and U.S. initial public offerings at the launch price before public trading begins, known as IPO access, with Apotex Health Corp. as its first offering. The Globe's Meera Raman writes that Mr. Platt requested 345 shares at a price of $20 to $24 per common share, an investment estimated at roughly $10,000. On Thursday, Wealthsimple also started offering IPO access to Elon Musk's aerospace company SpaceX, one of the most highly anticipated offerings of the year. Wealthsimple's retail clients are gaining access to IPOs that were once largely behind velvet ropes, with shares typically allocated to institutional investors and high-net-worth individual. As IPO excitement builds around sought-after companies such as Apotex, SpaceX and AI darling Anthropic, Canadian investment platforms are racing to give everyday investors earlier access to public offerings -- a shift that some financial experts say should be approached with caution. "Any time there's a democratization of some exotic product, it's not a good thing for retail investors," said PWL Capital chief investment officer Benjamin Felix.